Alzamend Neuro, Inc. (ALZN)
NASDAQ·Healthcare·Biotechnology
$1.19
+3.93%
Mkt Cap $6.84M
No analyst coverage available
We don't have analyst ratings or price target data for Alzamend Neuro, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.